Articles

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

PROTEOSTASIS THERAPEUTICS

ROSETTA

RECOMMANDATIONS

bonjour,...OREXIGENE THERAPEUTICS

AUROBINDO/CIPLA

Regeneron/Sanofi

changements aux indices

ALEXION

MYOKARDIA

AM-PHARMA..contre la septicémie